NCT02601924

Brief Summary

Eighty patients with inclusion criteria will participate in this studyEach patient will receive an injection in one of the following groups according to the random number table:

  1. 1.Group TPMB: Topical pressure and massage with an Inferior alveolar nerve block (IANB)
  2. 2.Group TGB: Topical gel of 20% Benzocain (Master-Dent, Monroe, NC) with IANB
  3. 3.Group TPMI: Topical pressure and massage with a maxillary anterior infiltration (MAI)
  4. 4.Group TGI: Topical gel with a MAI. Immediately after the injection, patients will be asked to record the amount of pain they felt during needle penetration and injection using VAS form.Data will be analyzed using ANOVA and t-test.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 11, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

January 15, 2019

Status Verified

January 1, 2019

Enrollment Period

1.8 years

First QC Date

November 7, 2015

Last Update Submit

January 12, 2019

Conditions

Keywords

Anesthesiainjectionpainpressure massagetopical gel

Outcome Measures

Primary Outcomes (1)

  • Pain rate using Visual Analog Scale(VAS)

    Topical anesthetic gel / pressure massage will be applied at the site of injection for 1 minute and anesthetic solution will be done during 1 minute

    2 minutes

Study Arms (4)

Topical Pressure Massage Block injection

ACTIVE COMPARATOR

Topical pressure massage at site of alveolar nerve block injection.

Other: Topical pressure massage

Topical Anesthetic Gel Block injection

ACTIVE COMPARATOR

Topical anesthetic gel (20% Benzocain) at site of inferior alveolar nerve block injection.

Drug: 20% Benzocain (Master-Dent, Monroe, NC)

Topical Pressure Massage Infiltration

ACTIVE COMPARATOR

Topical pressure massage at site of maxillary anterior infiltration

Other: Topical pressure massage

Topical Anesthetic Gel Infiltration

ACTIVE COMPARATOR

Topical anesthetic gel (20% Benzocain) at site of maxillary anterior infiltration

Drug: 20% Benzocain (Master-Dent, Monroe, NC)

Interventions

Two topical anesthetic gel groups will receive anesthetic gel at the site of injection with massage on treating tooth.

Also known as: Topical anesthetic gel
Topical Anesthetic Gel Block injectionTopical Anesthetic Gel Infiltration

Two topical pressure massage groups will receive topical placebo gel with pressure massage at the site of injection.

Topical Pressure Massage Block injectionTopical Pressure Massage Infiltration

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ranged18-65 years old
  • No systemic disease
  • Non pregnant or beast feeding
  • A mandibular premolar/molar or a maxillary anterior tooth with the diagnosis of normal pulp, reversible pulpitis or asymptomatic irreversible pulpitis (Heft Parker visual analogue scale ≤ 54)
  • Need dental treatment
  • Not taking analgesics, sedative or anti-anxiety medication during the last 24 hours
  • No intra oral injection at the treatment area during the last 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 7, 2015

First Posted

November 11, 2015

Study Start

February 1, 2016

Primary Completion

December 1, 2017

Study Completion

April 1, 2018

Last Updated

January 15, 2019

Record last verified: 2019-01